A Scientific Update of the Management of Systemic Sclerosis Interstitial Lung Disease

A Scientific Update of the Management of Systemic Sclerosis Interstitial Lung Disease

CME/CNE Symposium at the Congress of Clinical Rheumatology 2019

Event

CME/CNE Symposium at the Congress of Clinical Rheumatology 2019

Date

Friday, May 3rd, 2019
4:45-5:45pm

Location

Hilton Sandestin Beach Golf Resort & Spa
Emerald Ballroom


4000 S Sandestin Blvd
Miramar Beach, FL 32550

Overview

This CME/CNE dinner symposium during the Congress of Clinical Rheumatology 2019 will provide clinicians with an update on the hot topic of systemic sclerosis interstitial lung disease (SSc-ILD) as it relates to care in rheumatology. The expert faculty will review pathophysiology and recent treatment guidelines for accurate detection and diagnosis of SSc-ILD. New clinical trial data of SSc-ILD therapeutics will be analyzed, debating the clinical relevance in the rheumatology treatment landscape. Best practices for optimally managing patients with SSc-ILD and other comorbidities, particularly adverse events, will be highlighted. This CME/CNE activity will provide clinicians with practical information for improving care of systemic sclerosis interstitial lung disease patients.

Target Audience

Rheumatologists, pulmonologists, primary care physicians, internists, nurses, nurse practitioners, physician assistants, and other health care providers that are involved in the management of SSc-ILD

Location

Hilton Sandestin Beach Golf Resort & Spa
Emerald Ballroom
4000 S Sandestin Blvd
Miramar Beach, FL 32550

Agenda

  1. Systemic Sclerosis Interstitial Lung Disease: The Importance of Knowing Disease Pathophysiology and the Treatment Guidelines to More Effectively Diagnose Patients
  2. A Clinical Analysis of the Most Current Research for Emerging Therapeutics
  3. The Role of the Interprofessional Team to Improve Patient Education and Communication, as well as to Develop Treatment Regimens to Improve Outcomes

Educational Objectives

  1. Recognize the pathophysiology of SSc-ILD, as well as the treatment guidelines to more effectively diagnose and treat patients.
  2. Analyze clinical trial data for emerging therapeutics for the treatment of SSc-ILD.
  3. Utilize the interprofessional team to improve patient education and communication; and to develop more specific treatment regimens to improve outcomes.

Faculty

Lesley Ann Saketkoo, MD, MPH
Associate Professor Clinical Immunology
Associate Professor of Medicine
Tulane University
New Orleans, Louisiana

Mary Beth Scholand, MD
Director, Interstitial Lung Disease Clinic
Assistant professor in Pulmonary Medicine
The University of Utah
Salt Lake City, Utah

Accreditation Statement

Joint

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designation Statements

AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AcademicCME designates this live material for a maximum of 1.0 CNE contact hour. AcademicCME’s ANCC provider number is P0491.

CE Inquiries/Special Needs

For all CME/CNE inquiries or special needs, please contact [email protected] or 610-687-3300.

Financial Support

This activity has been supported by an independent educational grant from Boehringer Ingelheim.

 Provided by

AcademicCME-web

 

*This program is not part of the official Congress of Clinical Rheumatology 2019.

—-
Interested in attending other complimentary CME/CNE symposia discussing recent advances in the treatment and management of gout, osteoporosis and psoriatic arthritis during CCR 2019? Find more information and register today here: http://academiccme.com/ccr-landing/